Dr. Loretta Itri was most recently the EVP of Global Health Sciences & Regulatory Affairs at The Medicines Company, where she oversaw the development and regulatory approval of a variety of products, including cardiovascular drugs and antibiotics. Previously, she was President of Pharmaceutical Development and CMO at Genta, Inc. and SVP of Medical and Regulatory Affairs at the Robert Wood Johnson Pharmaceutical Research Institute and Ortho Biotech, where she oversaw the development and approval of a variety of therapeutic compounds.